McKesson

Cardinal Health

CMS Energy

Healthcare and Utilities Sectors Lead in Thursday Trading

卡地纳健康

Cardinal Health's 15min chart signals bearish trend with KDJ Death Cross, Bearish Marubozu.

Cardinal Health: Mizuho Keeps Outperform Rating, Raises PT to $235

Assessing Cardinal Health's Pricing Amidst Surge in Healthcare Supply Chain Role

Cardinal Health Triggers MACD and KDJ Death Crosses on 15-Minute Chart

Catalyst<ul> <li>Bullish bias from recent MACD Death Cross signals indicates growing positive momentum for CAH.</li></ul>Risk<ul> <li>Fund flow trends show net outflows in medium, large, and extra-large orders, suggesting declining institutional confidence.</li> <li>Fundamental analysis highlights weak revenue and operating cash flow growth, signaling potential profitability concerns.</li></ul>

Key Factors

Cardinal Health (CAH) reported Q2 FY26 revenue of $65.6 billion, a 19% year-over-year increase, and raised its FY26 non-GAAP EPS guidance to $10.15-$10.35. The company completed a $750 million share repurchase and achieved its targeted leverage range during Q2 FY26. Cardinal Health raised its annual profit forecast due to strong demand for specialty medicines and performance across its segments. Mizuho upgraded its price target for CAH to $235 and maintained its Outperform rating following the company's strong earnings and guidance.

Recent Updates

CAH News